Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages.
Gonzalez MA, Lu DR, Yousefi M, Kroll A, Lo CH, Briseño CG, Watson JEV, Novitskiy S, Arias V, Zhou H, Plata Stapper A, Tsai MK, Ashkin EL, Murray CW, Li CM, Winslow MM, Tarbell KV. Gonzalez MA, et al. Among authors: arias v. J Exp Med. 2023 Jun 5;220(6):e20221472. doi: 10.1084/jem.20221472. Epub 2023 Mar 30. J Exp Med. 2023. PMID: 36995340 Free PMC article.
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors.
Jirovec E, Quixabeira DCA, Clubb JHA, Pakola SA, Kudling T, Arias V, Haybout L, Jalkanen K, Alanko T, Monberg T, Khammari A, Dreno B, Svane IM, Block MS, Adamo DA, Mäenpää J, Kistler C, Sorsa S, Hemminki O, Kanerva A, Santos JM, Cervera-Carrascon V, Hemminki A. Jirovec E, et al. Among authors: arias v. J Exp Clin Cancer Res. 2024 Nov 6;43(1):297. doi: 10.1186/s13046-024-03219-0. J Exp Clin Cancer Res. 2024. PMID: 39506856 Free PMC article. Clinical Trial.
[Biopsychosocial Factors Influencing Mortality and Functional Recovery in COVID-19 Patients Undergoing Prone Positioning: A Prospective Observational Study].
Acevedo P F, Aravena C JM, Ceballos V F, Guzmán S MP, Maldonado M MJ, Torrealba G C, Duarte M A, Henríquez V N, Torrealba R K, Necuñir G F, Arias V J, Frei H A, Pérez R I. Acevedo P F, et al. Among authors: arias v j. Rev Med Chil. 2023 Nov;151(11):1427-1436. doi: 10.4067/s0034-98872023001101427. Rev Med Chil. 2023. PMID: 39270109 Free article. Spanish.
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine.
Basnet S, Van der Heijden M, Quixabeira DCA, Jirovec E, Grönberg-Vähä-Koskela SAM, Clubb JHA, Kanerva A, Pakola S, Haybout L, Arias V, Hemminki O, Kudling T, Zafar S, Cervera-Carrascon V, Santos JM, Hemminki A. Basnet S, et al. Among authors: arias v. Mol Ther. 2024 Aug 7;32(8):2800. doi: 10.1016/j.ymthe.2024.07.009. Epub 2024 Jul 19. Mol Ther. 2024. PMID: 39029457 Free PMC article. No abstract available.
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine.
Basnet S, Van der Heijden M, Quixabeira DCA, Jirovec E, Grönberg-Vähä-Koskela SAM, Clubb JHA, Kanerva A, Pakola S, Haybout L, Arias V, Hemminki O, Kudling T, Zafar S, Cervera-Carrascon V, Santos JM, Hemminki A. Basnet S, et al. Among authors: arias v. Mol Ther. 2024 Sep 4;32(9):3114-3127. doi: 10.1016/j.ymthe.2024.06.029. Epub 2024 Jun 22. Mol Ther. 2024. PMID: 38910324 Free PMC article.
151 results